CRUCELL NV
- Johnson & Johnson plans to buy Crucell for $2.3 bnJohnson & Johnson said Friday it is in advanced talks to acquire Dutch biotech firm Crucell NV for euro1.75 billion ($2.29 billion), a deal...
- Johnson & Johnson buys 18% stake in CrucellUS health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in biotechnology company Crucell NV for euro301.8 milli...
- Cadila acquires Italian vaccine research company Etna BiotechLeading Indian healthcare major Zydus Cadila said in a regulatory statement here Tusday that it has acquired Italy-based Etna Biotech, a wh...
- Load More